Our utility has spent more in the past few years since we became deregulated because it's the right thing to do. It's our job to be smarter about how to allocate precious resources.
Some of our more effective investments have been made in source term reduction. We all are working about as fast as you can and have installed as much lead as possible, so reducing the dose rates is the third option. Not all source term reduction actions come as a result of spending money, but a better understanding of managing the chemistry of the unit. None of us have all the answers, but sitting back and hoping the source term would get better wasn't one of the options in our decision making process. Outside of not reducing exposure, sitting back and not being engaged in continuous improvement is a quick way to slip from an INPO 1 to a 2 and that option is not supposed to exist in our business. Keep upholding the right standard! Glen Vickers, CHP Exelon Corp RP Technical Lead 815-216-2723 (work/cell) From: Mosty, Shari [mailto:[email protected]] Sent: Thursday, January 28, 2016 11:50 AM To: [email protected]<mailto:[email protected]> Subject: [powernet] dose vs dollar All, Are there any plants that have basically eliminated dose reduction from their station engineering programs for modifications. We have been told that some de-regulated plants have decided that the emphasis due to budgets is on repairs and that dose reduction when calculating dose vs dollar does not meet a high enough threshold. Any comments. Shari Mosty Sr. Health Physicist Comanche Peak Nuclear Power Plant 6322 N. FM 56 Glen Rose, Texas 76043 254.897.5204 [email protected]<mailto:[email protected]> Confidentiality Notice: This email message, including any attachments, contains or may contain confidential information intended only for the addressee. If you are not an intended recipient of this message, be advised that any reading, dissemination, forwarding, printing, copying or other use of this message or its attachments is strictly prohibited. If you have received this message in error, please notify the sender immediately by reply message and delete this email message and any attachments from your system. This Email message and any attachment may contain information that is proprietary, legally privileged, confidential and/or subject to copyright belonging to Exelon Corporation or its affiliates ("Exelon"). This Email is intended solely for the use of the person(s) to which it is addressed. If you are not an intended recipient, or the employee or agent responsible for delivery of this Email to the intended recipient(s), you are hereby notified that any dissemination, distribution or copying of this Email is strictly prohibited. If you have received this message in error, please immediately notify the sender and permanently delete this Email and any copies. Exelon policies expressly prohibit employees from making defamatory or offensive statements and infringing any copyright or any other legal right by Email communication. Exelon will not accept any liability in respect of such communications. -EXCIP
